Invention Grant
- Patent Title: Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
-
Application No.: US15300088Application Date: 2015-03-30
-
Publication No.: US10260068B2Publication Date: 2019-04-16
- Inventor: Kyosuke Hino , Junya Toguchida , Makoto Ikeya
- Applicant: Sumitomo Dainippon Pharma Co., Ltd. , Kyoto University
- Applicant Address: JP Osaka JP Kyoto
- Assignee: Sumitomo Dainippon Pharma Co., Ltd.,Kyoto University
- Current Assignee: Sumitomo Dainippon Pharma Co., Ltd.,Kyoto University
- Current Assignee Address: JP Osaka JP Kyoto
- Agency: Morgan, Lewis & Bockius LLP
- Priority: JP2014-071461 20140331
- International Application: PCT/JP2015/060015 WO 20150330
- International Announcement: WO2015/152183 WO 20151008
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K38/00 ; A61K38/16 ; C12N15/113 ; A61K31/7088 ; A61K31/7105 ; A61K31/713 ; A61K38/17 ; C07K14/47 ; C07K16/22 ; G01N33/50 ; A61P19/00 ; A61P19/04 ; G01N33/74
Abstract:
The invention provides a prophylactic agent or therapeutic agent for fibrodysplasia ossificans progressiva, containing as an active ingredient a binding inhibitor that inhibits interaction between activin and activin A receptor type I (ACVR1), or an expression suppressor that suppresses expression of activin.
Public/Granted literature
- US20170211070A1 Prophylactic Agent and Therapeutic Agent for Fibrodysplasia Ossificans Progressiva Public/Granted day:2017-07-27
Information query
